Analysts Set The Clorox Company (NYSE:CLX) Target Price at $101.00

Shares of The Clorox Company (NYSE:CLX) have been given a consensus rating of “Reduce” by the seventeen research firms that are currently covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a sell rating and twelve have given a hold rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $101.00.

Several research firms have recently weighed in on CLX. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a research note on Friday, July 10th. Morgan Stanley dropped their target price on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research report on Friday, May 1st. Evercore restated an “underperform” rating and issued a $98.00 price target on shares of Clorox in a report on Thursday, July 23rd. The Goldman Sachs Group restated a “sell” rating and issued a $83.00 price target on shares of Clorox in a report on Friday, May 1st. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Clorox from $95.00 to $92.00 and set an “underweight” rating for the company in a research note on Thursday, July 16th.

Clorox Trading Up 0.1%

CLX stock opened at $95.66 on Friday. The company has a market cap of $11.57 billion, a price-to-earnings ratio of 15.53 and a beta of 0.54. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The business has a fifty day simple moving average of $95.51 and a 200-day simple moving average of $103.64. Clorox has a 52 week low of $84.70 and a 52 week high of $128.90.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm’s quarterly revenue was up .1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.45 earnings per share. On average, equities research analysts expect that Clorox will post 5.52 EPS for the current year.

Insider Activity at Clorox

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of Clorox stock in a transaction that occurred on Tuesday, May 5th. The shares were acquired at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.63% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of CLX. Darwin Wealth Management LLC purchased a new stake in shares of Clorox during the 2nd quarter valued at about $29,000. Caitlin John LLC boosted its holdings in Clorox by 1,807.1% in the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after acquiring an additional 253 shares during the period. Root Financial Partners LLC grew its position in Clorox by 83.8% in the first quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after acquiring an additional 145 shares in the last quarter. Vision Financial Markets LLC raised its stake in shares of Clorox by 166.7% during the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after purchasing an additional 200 shares during the period. Finally, Western Wealth Management LLC purchased a new stake in shares of Clorox during the first quarter valued at approximately $35,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.